Organovo Holdings Inc (ONVO)
0.40
+0.05
(+14.32%)
USD |
NASDAQ |
Nov 22, 16:00
0.395
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Shareholders Equity (Quarterly): 3.68M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.68M |
June 30, 2024 | 6.662M |
March 31, 2024 | 3.601M |
December 31, 2023 | 6.182M |
September 30, 2023 | 8.456M |
June 30, 2023 | 11.78M |
March 31, 2023 | 15.33M |
December 31, 2022 | 22.29M |
September 30, 2022 | 25.01M |
June 30, 2022 | 27.65M |
March 31, 2022 | 30.21M |
December 31, 2021 | 31.29M |
September 30, 2021 | 34.21M |
June 30, 2021 | 37.33M |
March 31, 2021 | 39.20M |
December 31, 2020 | 20.75M |
September 30, 2020 | 19.99M |
June 30, 2020 | 24.79M |
March 31, 2020 | 26.63M |
December 31, 2019 | 28.95M |
September 30, 2019 | 31.07M |
June 30, 2019 | 36.14M |
March 31, 2019 | 36.30M |
December 31, 2018 | 35.68M |
September 30, 2018 | 38.87M |
Date | Value |
---|---|
June 30, 2018 | 41.36M |
March 31, 2018 | 44.59M |
December 31, 2017 | 48.60M |
September 30, 2017 | 52.06M |
June 30, 2017 | 57.27M |
March 31, 2017 | 62.36M |
December 31, 2016 | 70.90M |
September 30, 2016 | 52.49M |
June 30, 2016 | 54.84M |
March 31, 2016 | 62.18M |
December 31, 2015 | 69.04M |
September 30, 2015 | 76.15M |
June 30, 2015 | 85.32M |
March 31, 2015 | 48.70M |
December 31, 2014 | 48.31M |
September 30, 2014 | 53.43M |
June 30, 2014 | 43.82M |
March 31, 2014 | 48.28M |
December 31, 2013 | 48.70M |
September 30, 2013 | 51.94M |
June 30, 2013 | 6.908M |
December 31, 2012 | -5.303M |
September 30, 2012 | -27.42M |
June 30, 2012 | -71.76M |
March 31, 2012 | -37.39M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.601M
Minimum
Mar 2024
39.20M
Maximum
Mar 2021
21.20M
Average
23.54M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 2.912M |
IGC Pharma Inc | 7.377M |
NovaBay Pharmaceuticals Inc | 1.072M |
Protalix BioTherapeutics Inc | 32.44M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.754M |
Total Liabilities (Quarterly) | 3.074M |
Current Ratio | 1.981 |